Ohio sues 5 drug companies over opioid crisis
Suit seeks damages for money the state has spent on fallout
Ohio Attorney General Mike DeWine said on Wednesday his office sued five drug manufacturers, accusing them of misrepresenting the risks of prescription opioid painkillers, helping fuel a drug addiction epidemic.
A growing number of state and local governments are suing drugmakers and distributors, seeking to hold them accountable for the opioid crisis.
The five companies Ohio sued were Purdue Pharma LP, Johnson & Johnson's Janssen Pharmaceuticals Inc unit, a unit of Endo International Plc, Teva Pharmaceutical Industries Ltd's Cephalon unit and Allergan Plc, DeWine said during a press conference in Columbus livestreamed online.
- ANALYSIS | Opioid conflict-of-interest controversy reveals extent of big pharma's ties to doctors
- ANALYSIS | The year of the fentanyl crisis: How we got here
Janssen spokesman Jessica Castles Smith said in an emailed statement: "The allegations in this lawsuit are both legally and factually unfounded."
She said Janssen has acted responsibly regarding its opioid pain medications, which are approved by the U.S. Food and Drug Administration and carry FDA-mandated warnings on their labels about the drugs' known risks.
- Opioid epidemic fuelled by 1 paragraph in journal, doctors say
- Mandatory warning stickers on opioid prescription bottles to come
Purdue, which makes Oxycontin, said in an emailed statement: "We share the attorney general's concerns about the opioid crisis and we are committed to working collaboratively to find solutions."
Allergan and Teva declined to comment. Endo could not immediately be reached.
Crosses spectrum of society
The suit, filed in Southern Ohio where addiction has hit hard, seeks damages for the money the state has spent on the fallout, DeWine said.
Opioid drugs, including prescription painkillers and heroin, killed more than 33,000 people in the United States in 2015, more than any year on record, according to the U.S. Centers for Disease Control and Prevention.
In Michigan, a new unit is prosecuting crimes involving heroin and other opioid-based drugs as the state confronts an overdose epidemic that claimed almost 2,000 lives in 2015, Attorney General Bill Schuette said Wednesday.
The four-person Opioid Trafficking and Interdiction Unit in Schuette's office is designed to help local authorities target the supply of prescription drugs from dealers and doctors who are overprescribing. It was quietly launched in the fall and has netted six convictions. Fifteen other people are facing charges.
"It crosses the entire spectrum of our society. It really spares no one," Schuette said of opioid abuse during the Detroit Regional Chamber's Mackinac Policy Conference, where he was flanked by Genesee County Prosecutor David Leyton — his opponent in the 2010 election — and Schuette's chief deputy Matthew Schneider.
Schneider said the attorney general's office historically has partnered with county prosecutors on cold case investigations, murder probes and appellate cases.
"We are now reaching out on opioids, drug abuse cases. We've never done that before," he said.
The unit cooperates with local, state and federal authorities and focuses on major cases that cross state or county lines and involve high volumes of heroin and other opioid-based drugs. The unit plans to use what Schneider said is an underutilized law that allows murder charges against people who deliver drugs that cause someone to die.
With files from Associated Press